MedTrace Logo

Evaluation of the Effect of Botulinum Toxin Type-A Injection Prior to Surgical Correction of Complete Unilateral Cleft Lip Repair by Modified Millard Cheiloplasty

NCT03047499 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2

Last updated 2017-02-09

No results posted yet for this study

Summary

Evaluation of the effect of botulinum toxin type-A injection prior to surgical correction of complete unilateral cleftlip repair by modified millard cheiloplasty

Conditions

  • Esthetic Outcome of Injection of Botulinum Toxin Type-A in Cleft Lip Repair

Interventions

DRUG

Botulinum toxin type A

Botulinum toxin type-A injection

Sponsors & Collaborators

  • Mostafa Khairy

    lead OTHER

Eligibility

Min Age
3 Months
Max Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-15
Primary Completion
2017-10-15
Completion
2017-11-15
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03047499 on ClinicalTrials.gov